⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 3, 2024Open Access

Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Rona Yaeger Nataliya V. Uboha Meredith S. Pelster Tanios Bekaii‐Saab Minal Barve Joel Saltzman Joshua K. Sabari Julio A. Peguero Andrew Scott Paulson Pasi A. Jänne Marcia Cruz‐Correa Kenna Anderes Karen Velastegui Xiaohong Yan Hirak Der‐Torossian Samuel J. Klempner Scott Kopetz

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Supplementary Figure S2: Efficacy outcomes with adagrasib monotherapy in previously treated patients with KRASG12C-mutated unresecable or metastatic CRC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yaeger et al. (2024) studied this question.

synapsesocial.com/papers/68e5d8c3b6db64358756ee88 https://doi.org/10.1158/2159-8290.26490114.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
2Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
3Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
4Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
5Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024

Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024
Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i><sup>G12C</sup>-Mutated Metastatic Colorectal Cancer2024